Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N Yu, Safronova"'
Autor:
N. Yu. Safronova, G. D. Efremov, Andrey Kaprin, Dmitry S. Mikhaylenko, B. Ya. Alekseev, S. A. Sergienko
Publikováno v:
Experimental and Сlinical Urology. 12:42-51
Autor:
D. S. Mikhaylenko, S. A. Sergienko, I. N. Zaborsky, K. N. Saflullin, S. A. Serebryany, N. Yu. Safronova, M. V. Nemtsova, A. D. Kaprin, B. Ya. Alekseev
Publikováno v:
Onkourologiâ, Vol 14, Iss 4, Pp 124-138 (2019)
Bladder cancer (BC) is represented by non-muscle-invasive forms at the stage Ta, T1, CIS (NMBC) in 75 % of cases. The gold standard of treatment of NMBC patients is transurethral resection, but its implementation does not always allow the patient to
Autor:
D. S. Mikhaylenko, A. A. Novikov, M. V. Grigor’eva, G. D. Efremov, A. V. Sivkov, N. Yu. Safronova, K. S. Sorokin, M. Yu. Zemskova, M. V. Nemtsova, B. Ya. Alekseev, A. D. Kaprin
Publikováno v:
Onkourologiâ, Vol 13, Iss 3, Pp 54-60 (2017)
Introduction . Prostate cancer (PCa) is one of the common oncological diseases in men. Expression of the PCA3 gene in urine is currently used as a molecular genetic marker of PCa. Objective: to comparative analysis of the PCA3 expression in urine sed
Autor:
D S, Mikhaylenko, D V, Perepechin, M V, Grigoryeva, T A, Zhinzhilo, N Yu, Safronova, G D, Efremov, A V, Sivkov
Publikováno v:
Urologiia (Moscow, Russia : 1999). (5)
Morphological analysis of the biopsies for prostate cancer (PCa) often is a difficult task due to heterogeneity and multifocality of tumors. At the same time, a lot of data exist about the potential molecular genetic markers of PCa. The aim of our st
Publikováno v:
Bulletin of experimental biology and medicine. 162(3)
Molecular genetic analysis of KRAS, NRAS, and BRAF genes was carried out in order to develop an optimal algorithm for detection of minor mutations. We analyzed 35 melanoma and 33 colorectal cancer specimens. Frequent G12D/V/A/C/S mutations were detec